Riverside Shore Cancer Center is a clinical research site located in Onancock, Virginia, United States 23417.
Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.
Riverside Shore Cancer Center has participated in 4 clinical trials with 4 currently active.
Therapeutic areas: Colon Adenocarcinoma, Stage IIA Colon Cancer AJCC v8, Diffuse Large B-Cell Lymphoma.
Sponsors: NRG Oncology, National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Virginia · View every site in Onancock
Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Riverside Shore Cancer Center has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Riverside Shore Cancer Center has 4 clinical trials on record, with 4 currently active. Their work covers Colon Adenocarcinoma, Stage IIA Colon Cancer AJCC v8, Diffuse Large B-Cell Lymphoma.
Riverside Shore Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.